PharmaTher Holdings Ltd. Announces 2026 Strategy Including Asset Monetization, Strategic Partnerships for Ketamine Programs, and Plans to Crystallize Value from Sairiyo Therapeutics Equity Interest

Reuters · 01/02 13:01

Please log in to view news